Selenoneine, a Novel Selenium-Containing Compound, Mediates Detoxification Mechanisms against Methylmercury Accumulation and Toxicity in Zebrafish Embryo

Abstract

The selenium (Se)-containing antioxidant selenoneine (2-selenyl-N _α,N _α,N _α-trimethyl-l-histidine) has recently been discovered to be the predominant form of organic Se in tuna blood. Although dietary intake of fish Se has been suggested to reduce methylmercury (MeHg) toxicity, the molecular mechanism of MeHg detoxification by Se has not yet been determined. Here, we report evidence that selenoneine accelerates the excretion and demethylation of MeHg, mediated by a selenoneine-specific transporter, organic cations/carnitine transporter-1 (OCTN1). Selenoneine was incorporated into human embryonic kidney HEK293 cells transiently overexpressing OCTN1 and zebrafish blood cells by OCTN1. The K _m for selenoneine uptake was 13.0 μM in OCTN1-overexpressing HEK293 cells and 9.5 μM in zebrafish blood cells, indicating high affinity of OCTN1 for selenoneine in human and zebrafish cells. When such OCTN1-expressing cells and embryos were exposed to MeHg–cysteine (MeHgCys), MeHg accumulation was decreased and the excretion and demethylation of MeHg were enhanced by selenoneine. In addition, exosomal secretion vesicles were detected in the culture water of embryos that had been microinjected with MeHgCys, suggesting that these may be responsible for MeHg excretion and demethylation. In contrast, OCTN1-deficient embryos accumulated MeHg, and MeHg excretion and demethylation were decreased. Furthermore, Hg accumulation was decreased in OCTN1-overexpressing HEK293 cells, but not in mock vector-transfected cells, indicating that selenoneine and OCTN1 can regulate MeHg detoxification in human cells. Thus, the selenoneine-mediated OCTN1 system regulates secretory lysosomal vesicle formation and MeHg demethylation.

Electronic supplementary material

The online version of this article (doi:10.1007/s10126-013-9508-1) contains supplementary material, which is available to authorized users.

Introduction

Dietary intake of selenium (Se), which is found in fish, can reduce methylmercury (MeHg) toxicity (Friedman et al. 1978; Ganther and Sunde 1974; Ganther et al. 1972; Ohi et al. 1980; Raymond and Ralston 2004; Raymond et al. 2012). Ganther et al. (1972) demonstrated that intake of canned tuna meat containing slightly elevated MeHg levels reduced the toxicity to Japanese quail and suggested the protective role of Se. Friedman et al. (1978) showed a protective effect of freeze-dried swordfish meat against MeHg toxicity in rats, and Ohi et al. (1980) suggested that an unknown organic Se compound in fish meat could reduce MeHg neurotoxicity.

Recently, a novel Se compound, selenoneine, was identified in the blood of bluefin tuna and distributed in fish muscles (Yamashita and Yamashita 2010; Yamashita et al. 2010; 2011). The generation of reactive oxygen species (ROS) has been linked to MeHg-induced toxicity both in vivo and in vitro (Petroni et al. 2012; Yin et al. 2007; Usuki et al. 2011), and selenoneine has strong radical scavenging properties (Yamashita and Yamashita 2010; Yamashita et al. 2010, 2011). Thus, selenoneine is proposed to be a biologically and nutritionally active chemical with the ability to detoxify MeHg in animal cells and tissues.

With one Se atom in its imidazole ring, selenoneine is a Se analog of ergothioneine (Yamashita and Yamashita 2010). The organic cations/carnitine transporter, OCTN1 [solute carrier family 22, member 4; SLC22A4], transports ergothioneine and carnitine (Gründemann et al. 2005; Tamai et al. 1999) and therefore may also be involved in the uptake of selenoneine and its detoxification of MeHg. OCTN1 is ubiquitously distributed in mammalian cells and tissues, with erythrocytes having the highest OCTN1 mRNA levels (Gründemann et al. 2005; Tamai et al. 1999). Human embryonic kidney 293 (HEK293) cells transfected with an OCTN1 expression vector showed specific uptake of ergothioneine (Gründemann et al. 2005). The slc22a4 transporter gene has also been identified and expressed in zebrafish blood cells and other cell types, as expected given its role in heme metabolism (Nilsson et al. 2009; Weber et al. 2005).

To identify the MeHg excretion pathway mediated by the selenium redox function, we focused on the ceramide-mediated exosome secretion pathway. It has been shown recently that the formation and release of exosomes (small membrane-bound vesicles) by the endosomal sorting complex required for transport (ESCRT) machinery is triggered by ceramide generation (Trajkovic et al. 2008). Ceramide is produced by the hydrolytic action of sphingomyelinase (SMase) on substrate sphingomyelin in response to various agonists or stresses such as irradiation, heat shock, and oxidative stress (Hannun 1996; Mathias et al. 1993; Okazaki et al. 1989; Verheij et al. 1996; Yabu et al. 2008). The sphingomyelin pathway may be linked to stress-inducible apoptosis and detoxification under oxidative stress conditions produced by MeHg exposure.

Inorganic mercury (Hg) is distributed in marlin meat and in the livers and kidneys of fish and laboratory animals chronically exposed to MeHg (Clarkson 1972; Friberg and Mottet 1989; Itano et al. 1985; Ng et al. 2001; Nigro and Leonzio 1996; Palmisano et al. 1995; Skerfving 1978). Although demethylation of MeHg is thought to be an important route of detoxification, the underlying molecular mechanism is poorly understood. Therefore, the effects of chronic exposure to low MeHg levels should be characterized in animal models.

Bioaccumulation and detoxification of heavy metals in aquatic and marine organisms are important research topics in the field of marine biotechnology (Auslander et al. 2008; Cordeiro et al. 2012; De et al. 2008; Ma et al. 2012). The zebrafish is a useful model organism for studying embryonic development and is increasingly being used in vertebrate toxicology studies (Gonzalez et al. 2005; Korbas et al. 2008; Kusik et al. 2008; Samson et al. 2001; Weber et al. 2008). Previously, embryonic and larval zebrafish have been used to study the toxic effects of MeHg exposure on the entire body (Samson et al. 2001; Weber et al. 2008) and at the molecular level (Gonzalez et al. 2005; Korbas et al. 2008). Because the nucleotide sequence and expression of the zebrafish OCTN1 gene homolog has been characterized (Nilsson et al. 2009; Weber et al. 2005), OCTN1-deficient embryos can be generated by microinjection of an antisense morpholino oligo (MO) and used for the study of MeHg toxicity.

In the present study, we investigated the involvement of selenoneine and OCTN1 in MeHg detoxification using the zebrafish embryo model. The specific incorporation of selenoneine through OCTN1 was characterized in zebrafish embryos. In addition, the incorporation of selenoneine through the human homolog of OCTN1 was characterized in HEK293 cells. Morphological defects and apoptosis induced by MeHg were decreased by selenoneine exposure, and selenoneine reduced MeHg accumulation and induced demethylation of MeHg in embryos and HEK293 cells. Additionally, OCTN1-deficient zebrafish embryos showed excess accumulation of MeHg and increased sensitivity to MeHg exposure.

Materials and Methods

Materials

The dimeric oxidized form of selenoneine was purified from the blood of bluefin tuna according to methods described previously (Yamashita and Yamashita 2010). Ergothioneine and glutathione peroxidase 1 was purchased from Sigma-Aldrich Japan (Tokyo, Japan). Selenoneine and ergothioneine were dissolved in ultrapure water. MeHg–cysteine (MeHgCys) solution was prepared from MeHg chloride (STREM Chemicals, Newburyport, MA, USA) and L-cysteine hydrochloride (Wako Pure Chemical Industries, Osaka, Japan) according to the method described in the Mercury Analysis Manual (Ministry of the Environment, Japan 2004).

Fish Maintenance

Zebrafish (Danio rerio) were maintained at 28.5 °C on a 14 h light/10 h dark cycle, as described previously (Westerfield 1995). Fertilized one-cell stage embryos were collected from wild-type zebrafish and microinjected with linearized plasmid DNA at 0.5 ng per embryo or antisense MO at 10 ng per embryo using methods described previously (Yamashita et al. 2008). Microinjected zebrafish embryos (30 individuals) were cultured in Hank’s solution (Yamashita et al. 2008) in a 6-cm dish at 28.5 °C. To inhibit the lysosomal function, a vacuolar-type H⁺-ATPase inhibitor, bafilomycin A1 (baf; Wako Pure Chemical Industries), was added to the culture medium at a concentration of 5 nM 12 h post-fertilization (hpf), according to the manufacturer’s instructions. For the MeHgCys toxicity assay, zebrafish embryos were cultured in Hank’s solution, and eggs containing dead or obviously poor-quality embryos were removed. The remaining embryos were used, usually within 1 hpf, for developmental toxicity assays. Selenoneine treatment of embryos in 24-well microtiter plates began at 48 hpf. Symptoms in the zebrafish were continuously observed, and dead individuals were promptly removed. The number of deaths at 48 hpf was recorded.

Cell Culture and Transfection

HEK293 cells were obtained from the Health Science Research Resources Bank (Osaka, Japan) and cultured in RPMI-1640 (Invitrogen, Carlsbad, CA, USA) supplemented with 10 % fetal calf serum at 37 °C in a humidified 5 % CO₂ incubator. Linearized vector (phOCTN1) for human OCTN1 expression under the control of the human cytomegalovirus promoter (sc126568; Origene, Rockville, MD, USA) was transiently transfected into HEK293 cells using FuGene® HD Transfection Reagent (Roche Diagnotics Japan, Tokyo, Japan). The cells were cultured in a 24-well culture plate (Corning International, Tokyo, Japan) for 24 h after transfection, harvested by trypsinization (0.05 % trypsin/0.53 mM EDTA), washed twice with PBS, and collected by centrifugation.

Antisense MO

For knockdown experiments, two antisense MOs (antisense-MO1: CAT TTT AGC CTT CAG TTG CC and antisense-MO2: CGT GAT GTC GTC ATA ATC CCT CAT; Gene Tools, Boston, MA, USA) specific for zebrafish OCTN1 (Nilsson et al. 2009) were microinjected into one-cell stage zebrafish embryos (10 ng per embryo). Another MO with five mispaired bases (5′-mis control MO: CAA TTA AGG CTA CAC TTG CC) and a standard control oligo (control MO: CCT CTT ACC TCA GTT ACA ATT TAT A) (Gene Tools) were used as negative controls.

TUNEL Staining

Whole-mount TUNEL staining was performed as described previously (Yamashita et al. 2008).

Western Blot Analysis

Cultured cells and embryos were homogenized with 1/4 volume of 5× sample buffer [0.2 M Tris–HCl, pH 6.8, 10 % SDS, 10 mM 2-mercaptoethanol, 20 % glycerol, 0.05 % bromophenol blue, and protease inhibitor cocktail (Roche Diagnostics, Tokyo, Japan)], heated at 100 °C for 1 min, and clarified by centrifugation at 10,000×g for 10 min at 4 °C. The proteins were separated in a 10 % gel by SDS-PAGE and electroblotted onto a polyvinylidene difluoride membrane (GE Healthcare Japan, Tokyo, Japan). Polyclonal antibody against human OCTN1 (1:1,000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used as the primary antibody, with a horse radish peroxidase-conjugated secondary antibody (1:2,000 dilution, Daco Japan, Tokyo, Japan). Immunoreactive bands were detected using an ECL™ Western blotting detection kit (GE Healthcare Japan) according to the manufacturer’s protocol.

Selenium Concentration Measurement

Organic Se compounds were identified by speciation analysis using a previously described method (Yamashita and Yamashita 2010; Yamashita et al. 2011). Selenoneine and other Se-containing compounds were separated by chromatography using an Ultrahydrogel 120 column (7.8 × 250 mm; Nihon Waters, Tokyo, Japan) equilibrated with 100 mM ammonium formate buffer containing 0.1 % (w/v) Igepal CA-630 (Sigma-Aldrich Japan), and ⁸²Se was detected by online liquid chromatography–inductively coupled plasma mass spectrometry (LC-ICP-MS) performed using an ELAN DRC II mass spectrometer (PerkinElmer, Waltham, MA, USA). During separation, selenoneine was eluted at a retention time of 10.1 min, and the Se concentration was determined using selenoneine as a standard. For the Se assay of embryo tissues, embryos at 72 hpf were dissected with two pairs of fine forceps, and brains and blood cells were collected in PBS with a Pasteur pipette under a dissecting microscope. Pooled samples, each containing the tissues or blood cells of 10 embryos, were used for the selenium assay. The cells and tissues were homogenized in 100 mM ammonium formate buffer containing 0.1 % (w/v) Igepal CA-630 using a Polytron homogenizer (Kinematica, Luzernerstrasse, Switzerland) on ice, the cellular lysate was clarified by centrifugation at 10,000×g for 10 min, and the supernatant was used for Se determination. Total Se content in cellular extracts was analyzed by the flow injection method using LC-ICP-MS with selenoneine as a standard (Yamashita and Yamashita 2010). For the analysis of K _m values for selenoneine uptake, HEK293 cells transfected with OCTN1 and the blood cells collected from 72-hpf embryos were treated with selenoneine at concentrations from 1.6 to 32 μM in the culture medium. The K _m values were calculated by nonlinear regression of the Michaelis–Menten equation using Prism ver. 5 (GraphPad Software, La Jolla, CA, USA).

Hg Concentration Determination

After chemical digestion of samples with a 1:2:1 mixture of nitric acid/perchloric acid/sulfuric acid (Yamashita et al. 2005), total Hg levels were determined by flameless atomic absorption spectrometry at 253.7 nm, performed using an HG-310 mercury analyzer (Hiranuma, Tokyo, Japan) according to the manufacturer’s instructions. After inorganic Hg and MeHg were extracted from tissue samples using 5 M HCl and 0.25 M NaCl at 60 °C for 10 min (Reyes et al. 2009), inorganic Hg and MeHg were determined by LC-ICP-MS with a reverse-phase C18 column (Inertsil® Sulfa C18, 150 × 4.6 mm; GL Sciences, Tokyo Japan) by isocratic elution with 50 mM pyridine, 0.5 % (w/v) l-cysteine, and 5 % (v/v) methanol at pH 3 and room temperature.

ROS Assay

Hydroxyl radical concentrations were determined by measuring the fluorescence signal of hydroxyphenyl fluorescein (HPF; Sekisui Medical, Tokyo, Japan) according to the manufacturer’s instruction. Each embryo was placed in a 1.5-ml microcentrifuge tube and homogenized in diluted HPF solution (1:1,000 in ultrapure water) using a Pellet Mixer Pestle (Treff, Degersheim, Switzerland). After centrifugation at 10,000×g for 5 min, the fluorescence intensity of the extract was measured with a fluorescence spectrophotometer (model 850, Hitachi, Tokyo, Japan) at excitation and emission wavelengths of 490 and 515 nm, respectively. ROS levels were defined using arbitrary units of fluorescence intensity per milligram of protein.

Protein Determination

Protein concentrations were determined with a Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin (Sigma-Aldrich) as a standard.

Ultracentrifugal Separation of Exosomes from Culture Water of Embryos

After the microinjection of MeHgCys (3 ng Hg) into the yolk at 12 hpf and the removal of the chorion using forceps, zebrafish embryos (30 individuals) were cultured in Hank’s solution for 12 h. The MeHg and inorganic Hg contents of the embryos were determined. Embryo culture water (5 mL) was centrifuged at 3,000×g for 15 min at 4 °C to remove broken tissues and cells. The supernatant was layered above 20 mM Tris–HCl buffer (pH 7.4) containing 150 mM NaCl and 250 mM sucrose (10 mL) and ultracentrifuged at 100,000×g for 1 h at 4 °C. The pellet was suspended in 0.5 ml of 20 mM Tris–HCl buffer (pH 7.4) containing 150 mM NaCl and 0.1 % Tween-20, and used as the exosomal fraction. Cathepsin L activity was measured with Z-Phe-Arg-α-methylcoumaryl-7-amide (pH 5.6) as a substrate (Yamashita and Konagaya 1990). One unit of enzyme activity was defined as the release of 1 nmol of aminomethylcoumarin per hour at 37 °C.

Statistical Analysis

The results are expressed as means ± standard error. Differences among groups were analyzed using Prism ver. 5 (GraphPad Software).

Results

OCTN1 as the Selenoneine Transporter

Owing to the structural similarity between selenoneine and ergothioneine, we examined whether OCTN1, which is an ergothioneine transporter, could transport selenoneine by measuring Se incorporation in HEK293 cells transiently overexpressing OCTN1 transporter (Fig. 1). The overexpression of OCTN1 in HEK293 cells was confirmed by immunoblotting (Fig. S1). The addition of selenoneine to the cell culture medium caused Se levels in OCTN1-transfected cells to be 5.9 times those in mock vector-transfected cells. Selenoneine was incorporated into mock vector-transfected cells at a level 1.5 times that in selenoneine-untreated cells, suggesting that OCTN1 was also expressed in the control cells (Fig. 1).

Fig. 1.

Specific incorporation of selenoneine in HEK293 cells. HEK293 cells transiently transfected with mock control or phOCTN1 expression vector were assayed for the incorporation of selenium in the presence and absence of 3.2 μM selenoneine

OCTN1-deficient zebrafish embryos generated by microinjection of antisense MO1 showed reduced expression of OCTN1, as demonstrated by whole-mount immunostaining (Fig. S2A) and Western blot analysis (Fig. S1). When cultured in selenoneine-containing medium, the morphant OCTN1-deficient embryos showed reduced accumulation of selenoneine compared with that in control zebrafish embryos (Fig. 2, Fig. S2B), which incorporated selenoneine within 30 min of its addition to the culture medium (Fig. S3A, B). Thus, OCTN1 acted as a selenoneine transporter in human cells in vitro and in zebrafish embryos in vivo.

Fig. 2.

OCTN1-deficient zebrafish embryos microinjected with antisense morpholino oligo. Total selenium levels of embryos microinjected with 5-mis control MO and antisense MO1 in the presence and absence of selenoneine are compared. Asterisk indicates significant difference (ANOVA; P < 0.05)

We measured the specific uptake of selenoneine by HEK293 cells overexpressing OCTN1 and blood cells collected from a 3-day-old zebrafish embryo in medium containing 1.6–32 μM selenoneine. The K _m values for selenoneine uptake were estimated to be 13.0 and 9.5 μM, respectively. These were lower than those previously reported for ergothioneine uptake by OCTN1 (21 μM in OCTN1-transfected HEK293 cells) (Gründemann et al. 2005; Tamai et al. 1999). Because selenoneine was found to have a higher affinity for OCTN1, it may be the most specific ligand and is incorporated into cultured cells and embryos when present at micromolar concentrations.

Protective Effects of Selenoneine Against MeHg Accumulation and Toxicity

To evaluate the protective effect of selenoneine against MeHg accumulation, we established a zebrafish embryo-based method for testing MeHg toxicity. We assayed MeHg accumulation by measuring total Hg and Se contents in each embryo and observed morphological defects during embryogenesis in response to MeHgCys at 0–100 ng Hg/mL in the culture medium (Fig. 3). Abnormal morphogenesis occurred in a dose-dependent manner following treatment with MeHgCys at 25–100 ng Hg/mL. Following treatment with 100 ng Hg/mL, zebrafish embryos showed disruptions in the formation of the eyes, heart cavity, and larval fin at 48 hpf, and TUNEL-positive apoptotic cells were observed (Fig. 3d). We determined the frequency of defects in the eyes, heart cavity, and larval fin (Fig. S4).

Fig. 3.

Protective effect of selenoneine against MeHg accumulation in zebrafish embryos. Detection of apoptotic cells by whole-mount TUNEL staining in 2-day-old embryos after MeHgCys exposure. No apparent morphological defect was found in the control embryo (a), the embryo treated with only selenoneine (b), or the embryo treated with both MeHgCys and selenoneine (c). Embryos treated with only MeHgCys showed defects in the eyes, heart cavity, and larval fin, and apoptotic cells (d)

When exposed to only MeHgCys, the embryos accumulated MeHg in a dose-dependent manner (Fig. 4). In the absence of selenoneine, Hg levels reached 2.7 ng per embryo following treatment with MeHgCys at 100 ng Hg/mL, and intracellular Se levels were reduced to 56 % of the level observed in normal control embryos. However, in the presence of 1.6 μM selenoneine, Hg accumulation was decreased to 37 % of the level observed in embryos treated with MeHgCys only, and normal levels of Se were recovered (Fig. 4). In addition, inorganic Hg contributed 61 % of the total Hg content. Total Se levels in embryo brains and blood cells decreased in a dose-dependent manner after exposure to MeHgCys (Fig. S5A), and ROS were produced in MeHg-treated embryos (Fig. S5B). ROS level in embryos decreased at 100 ng Hg/mL compared with those at 25 and 50 ng Hg/mL, suggesting that oxygen consumption and ROS generation might decrease under severe oxidative stress condition at 100 ng Hg/mL of MeHg.

Fig. 4.

The selenium (a) and mercury (b) levels were measured in embryos after exposure to MeHgCys at 0–100 ng Hg/mL for 3 days in the presence and absence of selenoneine. The MeHg, inorganic mercury, and selenium levels were determined in cellular extracts. Values are means ± SE of eight individuals. Asterisks denote significant differences (ANOVA; P < 0.05)

We compared MeHg accumulation in embryos treated with selenoneine versus ergothioneine, a sulfur analog of selenoneine. Treatment of embryos that had accumulated MeHg with 0.8 or 1.6 μM ergothioneine did not reduce Hg levels (Fig. S6), indicating that MeHg accumulation is reduced only by selenoneine, and not by ergothioneine.

Essential Role of OCTN1 in MeHg Detoxification in Zebrafish Embryos and Human Cells

We used the zebrafish model to investigate the mechanism by which selenoneine detoxifies MeHg. To examine the relationship between OCTN1 function and MeHg accumulation in vivo, we measured the MeHg levels in zebrafish embryos that had been injected with an antisense MO and exposed to a low concentration of MeHgCys (10 ng Hg/mL; Fig. 5). After MeHg exposure, selenium levels in control embryos (5′-mis control MO1 and control MO) were reduced. In contrast, Hg was accumulated in OCTN1-deficient embryos (antisense MO1 and antisense MO2), and selenium levels were not reduced following MeHg exposure (Fig. 5).

Fig. 5.

Accumulation of mercury and selenium in zebrafish embryos after exposure to low concentrations of MeHg. After exposure to MeHgCys at 10 ng Hg/mL from 12 to 72 hpf, total selenium (a) and mercury (b) levels were determined in control embryos (5′-mis control MO1 and control MO) and in OCTN1-deficient embryos (antisense MO1 and antisense MO2). Values are means ± SE of six individuals. Asterisks indicate significant differences compared with 5′-mis control MO1 embryos (ANOVA; P < 0.05)

To confirm the finding that OCTN1-deficiency is associated with MeHg accumulation, we exposed zebrafish embryos to higher MeHgCys concentrations. Concentrations greater than 500 ng Hg/mL were lethal within 72 hpf, and abnormal morphogenesis was observed at 24 hpf (Fig. 6, Fig. S7). When control (5′-mis antisense MO1-injected) embryos were exposed to MeHgCys at 500 ng Hg/mL, the embryos died within 3 days (Fig. 6a); however, in the presence of 1.6 μM selenoneine, most embryos survived and produced inorganic Hg (Fig. 6b). Exposure to MeHgCys at 500 ng Hg/mL was always lethal to OCTN1-deficient embryos (Fig. 6a), which accumulated MeHg and died regardless of the presence of selenoneine (Fig. 6b). Nevertheless, with the addition of more selenoneine, survival increased from 54 to 87 % at day 1 and from 32 to 66 % at day 2 (Log-rank Mantel-Cox test; P < 0.0005), the Hg level decreased from 14.6 to 9.6 ng/embryo (Fig. 6b), and the morphological impact was reduced (Fig. S7).

Fig. 6.

Protective effect of selenoneine against lethal MeHg exposure. Zebrafish embryos were exposed to MeHgCys at 500 ng Hg/mL in Hank’s medium from 12 to 72 hpf, and the survival ratios were determined daily. a Survival ratios of antisense MO1-injected embryos and 5′-mis MO1-injected control embryos in the presence of MeHg (500 ng Hg/mL) and 0 or 1.6 μM selenoneine. Values are means ± SE (n = 38–58). Asterisks indicate significant differences between 5′-mis control MO1 and antisense MO1 embryos (Log-rank Mantel-Cox test; P < 0.0001). b Mercury levels in control embryos (5-mis control MO1) and OCTN1-deficient embryos (antisense MO1) at 24 hpf. Values are means ± SE of six individuals. Asterisks indicate significant differences between 5′-mis control MO1 and antisense MO1 embryos (ANOVA; P < 0.05)

To validate these data in human cells, HEK293 cells overexpressing human OCTN1 were exposed to MeHgCys in the absence and presence of selenoneine. In the absence of selenoneine, MeHg was accumulated in a dose-dependent manner in the OCTN1-overexpressing cells and the control empty vector-transfected cells (Fig. 7). Intracellular Se levels were reduced after exposure to MeHg at 25–100 ng Hg/mL. In the presence of selenoneine, the dose-dependent accumulation of MeHg was decreased. Furthermore, inorganic Hg was formed in OCTN1-overexpressing cells, but not in the control empty vector-transfected cells (Fig. 7).

Fig. 7.

Protective effects of selenoneine against MeHg accumulation in HEK293 cells. The cells transiently transfected with human OCTN1 cDNA or mock vector were treated with MeHgCys at 100 ng Hg/mL for 2 h in the presence and absence of selenoneine. The levels of a inorganic mercury and MeHg and b selenium were measured in cell extracts. Values and bars indicate means ± SE of three independent experiments. Asterisks denote significant differences between mock control and OCTN1-transfected cells (ANOVA, P < 0.05)

MeHg Detoxification by a Secretory Lysosomal Pathway

To further characterize MeHg detoxification mechanisms, we examined Hg accumulation following MeHgCys microinjection into the yolk. In control embryos, the intracellular Hg level decreased to 0.7 ng/embryo following microinjection of MeHgCys (3 ng Hg), and inorganic Hg was produced (1.1 ng/embryo; Fig. 8), indicating that most of the MeHg introduced into the embryos was excreted. In contrast, the Hg level increased to 2.2 ng/embryo in OCTN1-deficient embryos, and little inorganic Hg (0.1 ng/embryo) was produced (Fig. 8). Inhibition of the vacuolar-type H⁺-ATPase in lysosomes by baf enhanced MeHg accumulation by inhibiting the excretion of MeHg in the yolk.

Fig. 8.

Excretion of MeHg by the exosomal secretion pathway. The yolk sacs of embryos were microinjected with MeHgCys (3 ng Hg/individual embryo), and the mercury levels were measured. Values are means ± SE (n = 6). Asterisks indicate significant differences (ANOVA; P < 0.05)

To confirm the MeHg excretion mechanism, we collected exosomes from spent embryo culture medium and measured their Hg content and exosomal marker enzyme activity. Exosomes from the medium of MeHgCys-injected embryos contained higher levels of Hg than those from OCTN1-deficient embryo medium (Fig. 9). In addition, exosomes from OCTN1-overexpressing embryos contained markedly higher levels of Hg (Fig. 9a). Exosomes with high levels of Hg also exhibited increased activity of the lysosomal marker enzyme cathepsin L (Fig. 9b).

Fig. 9.

Total mercury content and cathepsin L activity in the exosomal fraction following MeHg exposure. Secreted exosomes were collected from the culture medium by ultracentrifugation at 100,000×g for 1 h. a Total mercury content in the exosomal fraction. b Activity levels of the lysosomal marker enzyme cathepsin L in the exosomal fraction. To inhibit lysosomal ATPase function, 5 nM baf was added to the culture medium at 12 hpf. Values and bars indicate means ± SE of three independent experiments. OCTN1-deficient embryos (antisense MO1) and control embryos (5′-mis control MO1) were compared. Asterisks indicate significant differences (ANOVA; P < 0.05)

DISCUSSION

In the present study, selenoneine reduced MeHg accumulation and toxicity in HEK293 cells and in a zebrafish embryo toxicity model. Selenoneine was identified as a high-affinity specific physiological ligand for OCTN1, with K _m values of 13.0 and 9.5 μM in HEK293 cells and zebrafish blood cells, respectively; previously, human OCTN1 was thought to specifically bind ergothioneine (K _m of 21 μM in HEK293 cells). Moreover, selenoneine was incorporated into human cells and zebrafish blood cells and embryos within 30 min. These findings show that OCTN1 regulates selenoneine absorption and Se metabolism in animal tissues. Given that selenoneine has strong radical scavenging activity (Yamashita and Yamashita 2010; Yamashita et al. 2010, 2011), the distribution and expression of OCTN1 may be responsible for maintenance of the Se redox status. In addition to cation absorption, mammalian OCTN1 is thought to be involved in the secretion of cations in renal proximal tubules and the small intestine (Kato et al. 2010). The present study showed that OCTN1 mediated the excretion of MeHg in human cells and zebrafish embryos, indicating a role in MeHg detoxification.

Selenoneine exists as two tautomers, the selenol- and selenoxo-form monomers, and an oxidized dimer (Yamashita and Yamashita 2010). For practical reasons, we used the stable oxidized dimer in the present study. When selenoneine was added to HEK293 culture medium, cell growth was enhanced and ROS levels were reduced (Yamashita et al. 2010). This suggests that the selenoneine oxidized dimer may be reduced by GSH, thus existing intracellularly as a reduced monomer and acting as a scavenger of radicals. OCTN1 and blood ergothioneine have been implicated in the etiology of Crohn’s disease (Koepsell et al. 2007; Koh et al. 2002). Therefore, selenoneine redox status, mediated by OCTN1, may be important in Crohn’s disease and other inflammatory and chronic diseases caused by Se deficiency and/or oxidative damage.

MeHg exposure was lethal to OCTN1-deficient embryos, which accumulated MeHg and died regardless of the presence of selenoneine. However, with the addition of more selenoneine, the survival of OCTN1-deficient embryos was increased, the level of Hg decreased, and the morphological impact of MeHgCys was much reduced. This suggests that in addition to OCTN1, other transporters may be involved in MeHg excretion; these transporters could belong to the solute carrier protein family (Koepsell et al. 2007; Maher et al. 2005) or the ATP-binding cassette (ABC) transporter ABC-B and ABC-C superfamily (Kato et al. 2010; Kruh and Belinsky 2003; Madejczyk et al. 2007; Maher et al. 2005; Paulusma et al. 1996; Taubert et al. 2005).

In the present study, detoxification of MeHg was mediated by the OCTN1. Upon exposure to MeHgCys, the Se level decreased in normal control embryos compared with OCTN1-deficient embryos, suggesting transport by OCTN1. The Hg level in control embryos was also lower than that in OCTN1-deficient embryos. In addition, the presence of exosomes with high levels of Hg and increased lysosomal cathepsin L activity suggests that exosome production is induced by MeHg exposure. Furthermore, baf inhibited MeHg excretion and enhanced its accumulation. These findings indicate that MeHg was excreted by the secretory lysosomal pathway through the function of OCTN1. The yolk was found to possess strong excretion and MeHg demethylation mechanisms mediated by the selenoneine–OCTN1 system.

Similar phenomena were also observed in OCTN1-transfected HEK293 cells, which showed decreased Se levels after MeHgCys treatment compared with the levels in mock vector-transfected cells, suggesting the transport of Se by OCTN1. Hg accumulation was decreased following selenoneine exposure in OCTN1-transfected cells, but not in mock vector-transfected cells, indicating that selenoneine and OCTN1 regulate MeHg detoxification in human cells. In OCTN1-transfected HEK293 cells, the Hg content decreased only in the presence of selenoneine. The difference in MeHg detoxification functions between zebrafish embryos and HEK293 cells may be attributable to different levels of endogenous OCTN1 expression and accumulated selenoneine. Zebrafish embryos expressed OCTN1 (Figs. S1 and S2), whereas HEK293 cells expressed OCTN1 only slightly (Fig. S1).

MeHg accumulation was inhibited in the presence of selenoneine in zebrafish embryo culture. This study clearly showed that OCTN1-deficient embryos microinjected with MeHgCys contained higher Hg levels than normal control embryos. Thus, we hypothesize that selenoneine-mediated MeHg excretion as a substrate of the OCTN1 transporter. Therefore, the protective mechanism may involve direct conjugation of selenoneine with MeHg. The selenoneine–MeHg complex might be formed under reducing conditions in vivo and translocated into the lysosomal secretory vesicles by OCTN1. Following this line of thought, the MeHg complex may be decomposed to inorganic Hg, i.e., mercury selenide (HgSe). HgSe found in the liver of marine mammals (Friberg and Mottet 1989; Itano et al. 1985; Ng et al. 2001; Nigro and Leonzio 1996; Palmisano et al. 1995; Skerfving 1978) may be produced from the selenoneine–MeHg complex by this OCTN1-mediated secretory lysosomal mechanism. In this study, however, no selenoneine–MeHg was detected in MeHg-exposed zebrafish embryos by LC-ICP-MS analysis. We speculate that the selenoneine–MeHg complex may be biologically unstable and readily decomposed in secretory lysosomal vesicles. In dolphin liver, the demethylation/accumulation of mercury probably involves the formation of HgSe and selenocompounds from Se-containing residues of specific proteins (Ng et al. 2001). In addition, the molar ratio of Se and inorganic Hg was very close to 1, suggesting that HgSe may be the end product of MeHg detoxification. Therefore, the MeHg detoxification mechanism in which selenoneine–MeHg complexes could be converted to HgSe by OCTN1 function may be commonly distributed in fish and mammals.

Because inorganic Se and selenomethionine supplementation can reduce MeHg toxicity (Friedman et al. 1978; Ganther et al. 1972; Ganther and Sunde 1974), selenoneine may be biologically synthesized from inorganic and/or organic Se in vivo and affect MeHg protection mechanisms. Our unpublished results using the OCTN1-deficient zebrafish embryos also show that OCTN1 mediates MeHg excretion in the presence of sodium selenite, suggesting that selenoneine produced from selenite may be used for MeHg detoxification (data not shown). Further studies should be undertaken to identify the roles of selenoneine in the Se metabolic pathway.

Recent studies on molecular excretion mechanisms have suggested that exosome vesicles are produced through stimulation by ceramide under oxidative stress conditions (Hannun 1996; Mathias et al. 1993; Okazaki et al. 1989; Verheij et al. 1996; Yabu et al. 2008). Thus, MeHg exposure may induce an oxidative stress response and formation of exosome vesicles containing MeHg and inorganic Hg. Exosome fractions containing mercury also showed lysosomal cathepsin L activity, implicating the endosomal and/or lysosomal secretion pathways (Nomura and Katsunuma 2005; Blott and Griffiths 2002). Ceramide generation by neutral sphingomyelinase triggers the formation and release of exosomes, and the ESCRT machinery is thought to play important roles in cell–cell communication, antigen presentation, and pathogenesis (Graner et al. 2009; Trajkovic et al. 2008). Thus, exosomal secretion mechanisms are also essential for MeHg detoxification. Under stress conditions, ceramide is produced by the hydrolytic action of sphingomyelinase on sphingomyelin, and c-jun kinase/stress-activated protein kinase pathways are linked to ceramide-induced cell death mechanisms (Hannun 1996; Mathias et al. 1993; Okazaki et al. 1989; Verheij et al. 1996; Yabu et al. 2008). Zebrafish embryos exhibited typical stress-inducible apoptotic features upon MeHg exposure. The detoxification of toxic chemicals and oxidants mediated by selenoneine appears to be a novel exosomal function in animal cells and tissues.

Taken together, these present findings support the hypothesis that MeHg excretion is mediated by selenoneine and a specific OCTN1, as proposed in Fig. 10. The depletion of selenoneine and production of ROS after MeHg exposure may trigger ceramide generation and exosome formation. Although a MeHg demethylation enzyme, similar to bacterial organomercury lyases (Begley et al. 1986), could be present in the MeHg secretion pathway, MeHg can be converted to inorganic Hg directly and non-enzymatically in the presence of Se (Iwata et al. 1982). Further study is required to identify the demethylation reaction and lysosomal vesicle formation mechanism.

Fig. 10.

Hypothesis for the influence of dietary intake of selenoneine on MeHg accumulation and toxicity. The main dietary source of selenoneine is fish, and it can be biologically synthesized from other selenium sources. Selenoneine plays an important role in selenium redox mechanisms. During MeHg exposure, selenoneine mediates the uptake of MeHg into endosomal and/or lysosomal secretion vesicles through OCTN1 function. MeHg exposure induces oxidative stress owing to the depletion of selenoneine and production of ROS. Stress-activated signaling mechanisms enhance proapoptotic ceramide signals, accelerating MeHg excretion. Demethylation occurs in the secretory lysosomal vesicles

In conclusion, we present a mechanism for selenoneine MeHg excretion and demethylation in human and fish cells. Selenoneine is an essential molecule in this detoxification pathway, and selenoneine and inorganic Hg levels may be useful biomarkers for MeHg detoxification in animal cells and tissues.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Abbreviations

ABC

ATP-binding cassette

baf

Bafilomycin A1

ESCRT

Endosomal sorting complex required for transport

Hg

Mercury

HgSe

Mercury selenide

HEK293

Human embryonic kidney 293 cell line

hpf

Hours post-fertilization

HPF

Hydroxyphenyl fluorescein

LC-ICP-MS

Liquid chromatography–inductively coupled plasma mass spectrometry

MeHg

Methylmercury

MeHgCys

MeHg–cysteine

MO

Morpholino oligonucleotide

OCTN1

Organic cations/carnitine transporter-1

phOCTN1

Human OCTN1 expression vector

ROS

Reactive oxygen species

Se

Selenium